Preclinical Information

Preclinical studies were carried out at MD Anderson Cancer Center Orlando and published data1 from extensive testing of our topical and injectable formulations in small animal studies conducted demonstrate the following: 

 

  • Protection of the skin from radiation-induced damage
  • Improved survival in animals given high doses of radiation
  • No detected toxicity at 1000X the effective dose
  • No interference with effectiveness of radiation on tumors

 

Projections by the clinical team at BioCurity are that the proposed formulations will have favorable stability profiles. 

 

 

1 Baker, CH. Radiation Protection with Nanoparticles. JSM. Nanotechnology Nanomedicine 2(1):1019,2014

 

 

 

 

 

Print Print | Sitemap
© Biocurity